{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:18:15Z","timestamp":1788049095157,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2021ZD0202904\/2021ZD0202900"],"award-info":[{"award-number":["2021ZD0202904\/2021ZD0202900"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82025033"],"award-info":[{"award-number":["82025033"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230115"],"award-info":[{"award-number":["82230115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304304"],"award-info":[{"award-number":["82304304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304471"],"award-info":[{"award-number":["82304471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119184","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:57:47Z","timestamp":1785995867000},"page":"119184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of novel brain-penetrant PARP7 inhibitors for the treatment of ischemic stroke"],"prefix":"10.1016","volume":"318","author":[{"given":"Wenxin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4385-3430","authenticated-orcid":false,"given":"Hongfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119184_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119184_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehs331","article-title":"Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia\/reperfusion brain injury","volume":"34","author":"Spescha","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2026.119184_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.apsb.2016.06.013","article-title":"The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119184_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119184_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"HERMES collaborators, endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119184_bib6","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119184_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCULATIONAHA.116.025724","article-title":"Stroke treatment with intravenous tissue-type plasminogen activator more proof that time is brain","volume":"135","author":"Alberts","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2026.119184_bib8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2015-08-662650","article-title":"ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice","volume":"127","author":"Denorme","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119184_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.apsb.2019.01.010","article-title":"Inhibition of FOXO3a\/BIM signaling pathway contributes to the protective effect of salvianolic acid A against cerebral ischemia\/reperfusion injury","volume":"9","author":"Song","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119184_bib10","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1161\/STROKEAHA.117.017283","article-title":"Reconsidering neuroprotection in the reperfusion era","volume":"48","author":"Savitz","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2026.119184_bib11","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1517\/14656566.2010.493558","article-title":"A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy","volume":"11","author":"Lapchak","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119184_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ccell.2021.06.018","article-title":"PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity","volume":"39","author":"Gozgit","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119184_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/acs.jmedchem.2c01452","article-title":"Discovery of the potent and highly selective PARP7 inhibitor as a novel immunotherapeutic agent for tumors","volume":"66","author":"Gu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib14","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15548627.2018.1458173","article-title":"Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke","volume":"14","author":"Han","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2026.119184_bib15","first-page":"643","article-title":"Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy","volume":"52","author":"Li","year":"2021","journal-title":"J. China Pharm. Univ."},{"key":"10.1016\/j.ejmech.2026.119184_bib16","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.3390\/molecules28155849","article-title":"Privileged scaffolds for potent and specific inhibitors of mono-ADP-ribosylating PARPs","volume":"28","author":"Nizi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119184_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712556","article-title":"The critical role of PARPs in regulating innate immune responses","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119184_bib18","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1021\/acs.jmedchem.2c00281","article-title":"Medicinal chemistry perspective on targeting mono-ADP-ribosylating PARPs with small molecules","volume":"65","author":"Nizi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/cells10020313","article-title":"MARTs and MARylation in the cytosol: biological functions, mechanisms of action, and therapeutic potential","volume":"10","author":"Challa","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119184_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/cells10010128","article-title":"Mono(ADP-ribosyl)ation enzymes and NAD+ metabolism: a focus on diseases and therapeutic perspectives","volume":"10","author":"Poltronieri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119184_bib21","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1523\/JNEUROSCI.0299-19.2019","article-title":"Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p\/TIPARP","volume":"39","author":"Wu","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119184_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107508","article-title":"New TIPARP inhibitor rescues mitochondrial function and brain injury in ischemic stroke","volume":"210","author":"Cai","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119184_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.jmedchem.3c01764","article-title":"Discovery of highly selective PARP7 inhibitors with a novel scaffold for cancer immunotherapy","volume":"67","author":"Gu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chembiol.2022.11.012","article-title":"Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-\u03b2 signaling","volume":"30","author":"Sanderson","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119184_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115836","article-title":"Exploring the structural-activity relationship of hexahydropyrazino[1,2-d]pyrido[3,2-b][1,4]oxazine derivatives as potent and orally-bioavailable PARP7 inhibitors","volume":"261","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116160","article-title":"Discovery of tricyclic PARP7 inhibitors with high potency, selectivity, and oral bioavailability","volume":"266","author":"Xu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib27","doi-asserted-by":"crossref","first-page":"19846","DOI":"10.1021\/acs.jmedchem.5c01335","article-title":"PARP7: an emerging therapeutic target-insights into biological functions and advances in small-molecule inhibitor development","volume":"68","author":"Qiu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119184_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0169-409X(95)00003-P","article-title":"Transport of small molecules through the blood-brain barrier: biology and methodology","volume":"15","author":"Pardridge","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.119184_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jps.10282","article-title":"Recent advances in the prediction of blood-brain partitioning from molecular structure","volume":"92","author":"Lobell","year":"2003","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119184_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/js980402t","article-title":"Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration","volume":"88","author":"Clark","year":"1999","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119184_bib31","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119184_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCULATIONAHA.120.045765","article-title":"Extracellular vesicle\u2013mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models","volume":"142","author":"Yang","year":"2020","journal-title":"Circulation"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600629X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600629X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:13:15Z","timestamp":1788048795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600629X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S022352342600629X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119184","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel brain-penetrant PARP7 inhibitors for the treatment of ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119184"}}